Lidocaine Intravenous in the Emergency Department For Sickle Cell Crisis

Clinical trial NCT04614610 · UNKNOWN

Trial details

NCT number: NCT04614610
Sponsor: Community Medical Center, Toms River, NJ
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Sickle Cell Disease Sickle Cell Crisis Pain, Acute

Start date: 2024-01-01
Primary completion: 2025-01-02
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.